Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Editas Medicine (EDIT) Shares Outstanding (Diluted Average): 2019-2025

Historic Shares Outstanding (Diluted Average) for Editas Medicine (EDIT) over the last 5 years, with Sep 2025 value amounting to $90.1 million.

  • Editas Medicine's Shares Outstanding (Diluted Average) rose 9.22% to $90.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $90.1 million, marking a year-over-year increase of 9.22%. This contributed to the annual value of $82.3 million for FY2024, which is 8.39% up from last year.
  • Per Editas Medicine's latest filing, its Shares Outstanding (Diluted Average) stood at $90.1 million for Q3 2025, which was up 6.73% from $84.4 million recorded in Q2 2025.
  • Editas Medicine's Shares Outstanding (Diluted Average)'s 5-year high stood at $90.1 million during Q3 2025, with a 5-year trough of $66.0 million in Q1 2021.
  • For the 3-year period, Editas Medicine's Shares Outstanding (Diluted Average) averaged around $80.4 million, with its median value being $82.3 million (2024).
  • Data for Editas Medicine's Shares Outstanding (Diluted Average) shows a peak YoY rose of 18.88% (in 2024) over the last 5 years.
  • Quarterly analysis of 5 years shows Editas Medicine's Shares Outstanding (Diluted Average) stood at $67.6 million in 2021, then rose by 1.55% to $68.7 million in 2022, then increased by 10.63% to $76.0 million in 2023, then rose by 8.39% to $82.3 million in 2024, then rose by 9.22% to $90.1 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $90.1 million in Q3 2025, compared to $84.4 million in Q2 2025 and $83.1 million in Q1 2025.